Stereotaxis

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

benzingaai2023_modern_computer_screen_with_stock_chart_stock__c8dae12f-563b-4c3d-ba96-79a17f4c62e4_0

News

Movers

NVDA

STXS

Stereotaxis shares are moving higher on Wednesday after the company announced it was accepted into the NVIDIA Connect program.

What&#39;s Going On With Stereotaxis Shares Wednesday?

Biotech

Earnings

Earnings Beats

Penny Stocks

Small Cap

Markets

Analyst Ratings

Trading Ideas

General

AXGN

AxoGen (NASDAQ: AXGN) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of a loss of $0.05 per share. This compares to loss of $0.03 per share a year ago. These figures are adjusted for non-recurring items.

AxoGen Q2 Earnings and Revenues Beat Estimates

penny stock tips 3

Long Ideas

Insider Trades

Pre-Market Outlook

Mobile Infrastructure Corporation Common Stock

BEEP

FPAY

HYLN

Hyliion Holdings And 3 Other Penny Stocks Insiders Are Buying

Stereotaxis Inc

Health Care

Press Releases

Oulu University Hospital Enhances Leadership in Arrhythmia Care with Advanced Genesis Robotic Technology

Stereotaxis Receives CE Mark Approval for the MAGiC Ablation Catheter

Contracts

Stereotaxis Announces First GenesisX Robotic System Order

Stereotaxis to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Stereotaxis to Present at 45th Annual TD Cowen Healthcare Conference

Stereotaxis Reports 2024 Full Year Financial Results

Stereotaxis Submits First Ever Robotically Navigated High-Density EP Mapping Catheter for Regulatory Clearance

Stereotaxis Submits EMAGIN Catheter for Regulatory Clearance as it Pioneers Robotics for Endovascular Surgery

Stereotaxis to Present at 37th Annual Roth Conference

Stereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect Program

Accuray

Anteris Technologies Global Corp. - Common Stock

Anteris Technologies

Baird Medical Investment Holdings Ltd - Ordinary Share

Baird Medical Investment

BrainsWay Ltd. - American Depositary Shares

BrainsWay

Alpha Tau Medical

EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share

Edap TMS

Electromed

Fonar

Inogen

Kewaunee Scientific Corporation - Common Stock

Kewaunee Scientific

KORU Medical Systems, Inc. - Common Stock

KORU Medical Systems

LENSAR

Lucid Diagnostics

Monogram Technologies Inc. - Common Stock

Monogram Technologies

Milestone Scientific

Myomo

Nevro

Orchestra BioMed Holdings, Inc. - Ordinary Shares

Orchestra BioMed Hldgs

Odysight ai

Outset Medical

Pro-Dex

Sight Sciences

Sensus Healthcare

JIN MEDICAL INTERNATIONAL LTD. - Ordinary Shares

Jin Medical International

Zynex

Lake Street

Roth MKM

Piper Sandler

B. Riley Securities

Cowen & Co.

Comments

Stereotaxis

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga